Global MRI Contrast Agents Market Report, History and Forecast 2017-2028
Summary
Market Analysis and Insights: Global MRI Contrast Agents Market
Due to the COVID-19 pandemic, the global MRI Contrast Agents market size is estimated to be worth US$ 1384.86 million in 2021 and is forecast to a readjusted size of US$ 2110.73 million by 2028 with a CAGR of 5.87% during the review period.
The global main manufacturers of MRI Contrast Agents include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, and etc. In 2021, the global six largest players have a share approximately 94.07% in terms of revenue.
The North America MRI Contrast Agents market is estimated at US$ 462.57 million in 2021, while China is forecast to reach US$ 489.74 million by 2028. The proportion of the China is 17.77% in 2021 and it is predicted that the share will reach 23.20% in 2028, trailing a CAGR of 9.65% through the analysis period. As for the Europe MRI Contrast Agents landscape, Germany is projected to reach US$ 136.01 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 4.68% and 6.63% respectively for the next 6-year period.
Gadoterate Meglumine accounting for 27.37% of the MRI Contrast Agents global market in 2021, is projected to value US$ 563.17 million by 2028, growing at a revised 5.49% CAGR in the post-COVID-19 period. While Hospitals segment is altered to an 7.44% CAGR throughout this forecast period and will hold a share about 85.00% in 2028.
Global MRI Contrast Agents Scope and Market Size
The global MRI Contrast Agents market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global MRI Contrast Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
Korea
India
Taiwan
Southeast Asia
Australia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook